top of page

Laxxon's Oral GLP-1 Agonist Treatment, LXM.2, Granted Funding by ESF Plus and the Free State of Thuringia
Laxxon has received a grant by Freistaat Thüringen and the ESF Plus (European Social Fund) for the further development of LXM.2.
Laxxon Medical
Mar 114 min read

Laxxon's New Generation Levodopa/Carbidopa Treatment, LXM.5, Granted Funding by ESF Plus and the Free State of Thuringia
Laxxon's New Generation Levodopa/Carbidopa for Parkinson's Disease project, LXM.5, has been awarded a grant.
Laxxon Medical
Feb 112 min read

Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LXM.5
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery...
Laxxon Medical
Feb 43 min read

Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug...
Laxxon Medical
Jan 153 min read

Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2024 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of...
Laxxon Medical
Jan 71 min read

Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tablet Form at 2024 BIO-Europe Convention, Aiming to Enhance Compliance for Special Patient Groups
Laxxon is seeking out-licensing opportunities for lead asset LXM.2, or co-developments projects with 3DSP platform technology SPID® at...
Laxxon Medical
Oct 14, 20243 min read


Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP fa
Laxxon Medical
Oct 2, 20243 min read

Investing in Safety: Laxxon Medical's QR Code Technology and the Fight Against Counterfeit Drugs
Counterfeit medicine is a threat to public health. Technologies like 3D printing and QR codes help protect both patients and drug integrity.
Laxxon Medical
May 20, 20246 min read


Understanding GLP-1 Medications for Diabetes and Obesity
Learn all about GLP-1 medications for diabetes and obesity, including benefits, side effects, and how they work.
Laxxon Medical
May 6, 20245 min read


The Controlled Release Drug Delivery Market
Explore the future of drug delivery, Laxxon Medical's innovative 3D technology, and how controlled-release drugs are reshaping healthcare.
Laxxon Medical
Apr 29, 20243 min read


Revolutionizing Parkinson's Treatment: How Laxxon's Extended-Release Levodopa Improves Quality of Life
Laxxon's extended-release Levodopa is revolutionizing Parkinson's treatment, increasing patient quality of life with improved medication.
Laxxon Medical
Apr 22, 20246 min read


The Potential of 3D Screen Printing to Combat Counterfeit Medication
3D screen printing could revolutionize the fight against counterfeit medication, innovating anti-counterfeiting measures for patient safety.
Laxxon Medical
Apr 8, 20243 min read


Digital Tools In the Healthcare Industry: Addressing Counterfeit Medicine and Safety
Learn how Laxxon Medical's 3D screen printing and QR codes combat counterfeit medicine. Discover the impact on safety and global healthcare.
Laxxon Medical
Apr 1, 20243 min read


Breaking Down Obesity: Understanding Its Effects and Navigating Treatment Options
Delve into the complexities of obesity, from its global impact to the physical, mental, and social effects, and various treatment options.
Laxxon Medical
Mar 18, 20247 min read


Understanding Diabetes: A Comprehensive Guide to Causes, Effects, and Modern Treatments
Discover the world of diabetes, from causes to treatments. Explore the latest research and advancements in managing this complex disease.
Laxxon Medical
Mar 4, 202413 min read


The Role of Patent Extensions in Healthcare: Balancing Innovation and Access
Explore the delicate balance between pharmaceutical patent extensions and patient access in healthcare and it's role in driving innovation.
Laxxon Medical
Feb 19, 20243 min read

The Impact of Technology on Pharmaceutical Research: Speed, Efficiency, and Accuracy
Discover how technology like Generative AI, IoMT, and 3D Printing is accelerating pharma research, enhancing speed, efficiency and accuracy.
Laxxon Medical
Feb 12, 20244 min read


What Is the FDA 505b2 Pathway?
Learn about the FDA 505b2 Pathway, a streamlined NDA process benefiting pharmaceutical companies with reduced costs and faster drug approval
Laxxon Medical
Jan 29, 20243 min read


Advancing medication with the right DDS: Pulsatile release
Discover how pulsatile release drug delivery systems can revolutionize medication efficacy, and the treatment of various conditions.
Laxxon Medical
Jan 22, 20247 min read


Revolutionizing Pharma: 3D Screen Printing and Smart Technologies Shaping the Future of Medicine
3D printing and smart technologies are transforming the pharma industry. From personalized medicine to revolutionizing drug delivery.
Laxxon Medical
Jan 15, 20247 min read
bottom of page